ZAREEN BABAR: Open Payments
NPI 1649406018 · CULPEPER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 49 payments from 14 companies in 2025. Trend: 2023 $803 · 2024 $1,135 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $333 |
| Novo Nordisk Inc | 10 | $207 |
| Lilly USA, LLC | 4 | $94 |
| ABBVIE INC. | 4 | $94 |
| PFIZER INC. | 4 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Exact Sciences Corporation | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| ALK-Abello, Inc | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: AIRSUPRA, Ozempic, UBRELVY, FARXIGA, BREZTRI, JARDIANCE, KISUNLA, MOUNJARO.
Industry payments across VA — which companies pay providers there.
